- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-8190
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
How COVID-19 induces cytokine storm with high mortality ; volume:40 ; number:1 ; day:1 ; month:10 ; year:2020 ; pages:1-7 ; date:12.2020
Inflammation and regeneration ; 40, Heft 1 (1.10.2020), 1-7, 12.2020
- Urheber
-
Hojyo, Shintaro
Uchida, Mona
Tanaka, Kumiko
Hasebe, Rie
Tanaka, Yuki
Murakami, Masaaki
Hirano, Toshio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41232-020-00146-3
- URN
-
urn:nbn:de:101:1-2020111917563330784754
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hojyo, Shintaro
- Uchida, Mona
- Tanaka, Kumiko
- Hasebe, Rie
- Tanaka, Yuki
- Murakami, Masaaki
- Hirano, Toshio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment Options during Cytokine Storm
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
COVID-19: more than a cytokine storm
Cytokine storms during alemtuzumab infusion: a case series
Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
Injectable Porous Silicon Nanoparticles as a Plasma Cytokine Scavenger for Potentiating Cytokine Storm Syndrome Treatment
Injectable Porous Silicon Nanoparticles as a Plasma Cytokine Scavenger for Potentiating Cytokine Storm Syndrome Treatment
Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity
De novo design of miniprotein antagonists of cytokine storm inducers
Mitochondrial impairment in oligodendroglial cells induces cytokine expression and signaling
Treatment Options during Cytokine Storm
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
COVID-19: more than a cytokine storm
Cytokine storms during alemtuzumab infusion: a case series
Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
Injectable Porous Silicon Nanoparticles as a Plasma Cytokine Scavenger for Potentiating Cytokine Storm Syndrome Treatment
Injectable Porous Silicon Nanoparticles as a Plasma Cytokine Scavenger for Potentiating Cytokine Storm Syndrome Treatment
Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity
De novo design of miniprotein antagonists of cytokine storm inducers
Mitochondrial impairment in oligodendroglial cells induces cytokine expression and signaling
Treatment Options during Cytokine Storm
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
COVID-19: more than a cytokine storm
Cytokine storms during alemtuzumab infusion: a case series
Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
Injectable Porous Silicon Nanoparticles as a Plasma Cytokine Scavenger for Potentiating Cytokine Storm Syndrome Treatment
Injectable Porous Silicon Nanoparticles as a Plasma Cytokine Scavenger for Potentiating Cytokine Storm Syndrome Treatment
Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity
De novo design of miniprotein antagonists of cytokine storm inducers